Standard RNA-seq captures the transcriptome but cannot distinguish transcriptionally regulated genes from translationally regulated ones. Polysome profiling combined with RNA-seq determines translation efficiency (TE) for every transcript, revealing which genes are actually being translated.
Service Highlights:

The relationship between steady-state mRNA abundance and protein output is not linear. Across multiple model systems — from yeast to mammalian cells — mRNA abundance accounts for only 40–60% of the variance in protein levels. RNA-seq alone cannot resolve this gap.
Polysome profiling closes this gap by directly measuring the fraction of each mRNA species that is engaged with multiple ribosomes — the strongest proxy for active translation. By sequencing both total RNA and polysome-bound RNA from the same sample, we calculate TE for every detectable transcript. The key output: genes whose TE changes significantly between conditions, independent of their total abundance — revealing regulation that RNA-seq alone would miss. For complementary techniques, see our Ribo-seq Service for codon-level resolution.
When is this approach essential? Your RNA-seq data shows few expression changes, but you suspect translational regulation (common with mTOR/PI3K/AKT perturbations). Your proteomics data disagrees with your RNA-seq — you need a mechanistic explanation. You identified a novel transcript but need to determine whether it is translated.
| Technology | Resolution | Readout | Best For | Limitations |
|---|---|---|---|---|
| Polysome Profiling + RNA-seq | Transcript-level | TE, polysome occupancy, differential translation | Broad translatome profiling, multi-omics integration | No nucleotide-resolution ribosome positioning |
| Ribo-seq (Ribosome Footprinting) | Codon-level | Ribosome-protected fragments, A-site occupancy | Alternative start sites, uORFs, ribosome pausing | Shorter fragments, higher RNA input, more complex bioinformatics |
| RNC-seq | Transcript-level | Native ribosome-nascent chain complexes | Direct capture of active translation without gradient | Lower throughput, more specialized equipment |
| Disome-seq | Codon-level | Disome-protected fragments | Stalled or collided ribosomes, ribosome quality control | Very specialized, not for routine TE measurement |
| TRAP-seq | Cell-type-level | Cell-specific translating mRNAs | In vivo cell-type-specific translatomics | Requires transgenic animals or viral constructs |
For most researchers studying genome-wide translational regulation in response to drug treatment, stress, disease state, or differentiation, Polysome Profiling + RNA-seq offers the best balance of throughput, depth, and interpretability. It captures full-length transcripts and supports multi-omics integration with proteomics or metabolomics. Explore our full translatomics sequencing services portfolio for additional options.
Our streamlined workflow covers every step from sample receipt to final report, requiring no prior expertise from the client.
Cells must be treated with cycloheximide (100 μg/mL, 10 min, 37°C) to freeze elongating ribosomes on mRNAs. Samples are lysed in polysome extraction buffer. RIN ≥ 7 required.
Lysates are loaded onto 10–50% linear sucrose gradients and ultracentrifuged at 35,000 rpm for 2.5 h at 4°C using a SW41 Ti rotor.
Gradients are fractionated with continuous UV absorbance monitoring at 254 nm. Fractions are pooled into total RNA and polysome-bound RNA (≥2 ribosomes).
RNA is extracted, DNase treated, rRNA depleted, and used for dUTP-based strand-specific library preparation.
Libraries are sequenced on Illumina NovaSeq 6000, 150 bp paired-end, ≥30M reads per sample for both total and polysome-bound RNA-seq.
Alignment (STAR) → quantification (featureCounts) → TE calculation → differential analysis → deltaTE classification → GO/KEGG enrichment.

Our bioinformatics pipeline goes beyond simple TE calculation to provide mechanistic insight.
TE = Polysomal RPKM / Total RPKM for each transcript. Only genes with ≥10 reads in both fractions are included.
We apply a moderated t-test to identify transcripts with significantly changed TE (|ΔTE| ≥ 1.5-fold, adjusted p-value < 0.05).
| Behavioral Class | Total RNA | Polysomal RNA | TE | Biological Interpretation |
|---|---|---|---|---|
| Purely transcriptional | ↑ or ↓ | ↑ or ↓ | = | mRNA production or stability changed |
| Purely translational | = | ↑ or ↓ | ↑ or ↓ | Ribosome recruitment or initiation changed |
| Combined (same direction) | ↑ or ↓ | ↑ or ↓ | ↑ or ↓ | Both transcription and translation reinforce |
| Combined (opposing) | ↑ or ↓ | ↓ or ↑ | ↓ or ↑ | Transcriptional compensation or buffering |
For detailed bioinformatics methods, refer to our RNC-seq Service which uses a complementary approach to capture native ribosome-nascent chain complexes.
Oncogene addiction, tumor suppressor loss, and drug resistance frequently operate through translational mechanisms. eIF4E-dependent translation of cyclin D1 and c-MYC drives proliferation; mTORC1 hyperactivation promotes TOP mRNA translation.
m6A, m7G modifications regulate translation through reader proteins. Polysome profiling distinguishes whether an m6A perturbation alters transcript abundance or directly affects TE.
Compounds targeting translation (mTOR inhibitors, eIF4A inhibitors) produce characteristic TE signatures. Our enhanced ribosome profiling service can further resolve drug-induced ribosome pausing events.
TDP-43 and FUS pathology in ALS/FTD disrupt stress granule dynamics. Polysome profiling quantifies which mRNAs are excluded from polysomes under stress conditions.
During stem cell differentiation, the translatome shifts before the transcriptome responds. Polysome profiling captures these early events, providing insight into lineage commitment.
T cell activation and cytokine production involve rapid translational reprogramming that precedes transcriptional changes.
| Parameter | Requirement | Notes |
|---|---|---|
| Cell number | ≥ 4 × 10⁷ cells per condition | Contact us for low-input optimization |
| Tissue weight | ≥ 400 mg fresh-frozen tissue | Snap-frozen in liquid N₂, store at -80°C |
| Biological replicates | ≥ 3 per condition | 4-5 recommended for small TE changes |
| CHX treatment | Required for cell samples | Protocol provided: 100 μg/mL, 10 min at 37°C |
| Shipping | Dry ice, Mon-Wed | Overnight delivery, avoid freeze-thaw |
| Sample type | Cultured cells, fresh-frozen tissue | FFPE and RNAlater NOT compatible |
| Turnaround | 11–13 weeks | Depends on sample number and depth |
Sample submission checklist: CHX-treated cells → PBS wash → flash-freeze → 4×10⁷ cells/replicate → 3+ replicates/condition → ship dry ice Mon-Wed → complete submission form.
Below are representative data outputs from a typical polysome profiling + RNA-seq project.
Global translation efficiency distribution across conditions. Histogram bins from TE = 0 to TE = 4, with a right shift indicating increased global translation. Key features: median TE per condition, fraction of transcripts with TE > 1, and the proportion of highly translated (TE > 2) transcripts.
Volcano plot showing ΔTE (log2 fold change) against statistical significance (−log10 adjusted p-value). Translationally upregulated genes in red, downregulated in blue. Key targets: oncogenes (MYC, CCND1), stress response factors (ATF4, HSPs), and metabolic enzymes (LDHA, PKM2) highlighted with gene labels.
KEGG pathway enrichment heatmap showing which signaling pathways are enriched among translationally regulated genes. Color intensity reflects enrichment significance. Top pathways: mTOR signaling, PI3K-Akt, proteasome, ribosome biogenesis, and spliceosome.

Figure 1. Polysome Profiles Across Differentiation
UV absorbance traces at 254 nm showing polysome profiles at Day 0 (pluripotent) and Day 30 (mature cardiomyocytes), with increased polysome-to-monosome ratio indicating elevated translation activity in differentiated cells.
Figure 2. TE Heatmap of Cardiac Transcription Factors
Heatmap showing translation efficiency changes of key cardiac transcription factors (MEF2C, GATA4, NKX2-5, TBX5) across five differentiation time points.
Figure 3. Transcriptional vs. Translational Regulation
Venn diagram showing that ~40% of translationally regulated genes showed no change in total RNA levels, highlighting the unique value of integrated translatomics.
Background
Polysome profiling followed by RNA-seq was performed on hESCs across five cardiac differentiation time points to characterize translational regulation during lineage commitment.
Methodology
hESCs were differentiated toward cardiomyocytes. Polysome profiling + RNA-seq was performed at Day 0 (pluripotent), Day 3 (mesoderm), Day 7 (cardiac mesoderm), Day 14 (early cardiomyocytes), and Day 30 (mature cardiomyocytes).
Key Findings
Over 500 transcripts showed significant TE changes (≥2-fold, FDR < 0.05). ~40% of these showed no change in total RNA levels. Translatome changes preceded transcriptional changes by 3–5 days.
Significance
This study demonstrates that polysome profiling captures early translational events missed by RNA-seq alone, providing a unique window into differentiation mechanisms. Source: Pereira IT, et al. Scientific Data. 2018;5:180287 (Fig. 3, CC BY 4.0).
*This service is for research use only (RUO). Results are intended for scientific research purposes and are not intended for clinical diagnosis, treatment, or therapeutic decision-making.